What Should Be Chronic: The Animal, the Model, or Both?

Por Rubio, Gustavo A., Elliot, Sharon J., Glassberg, Marilyn K.
Publicado no Stem Cells Transl Med (2016)

Reply: Idiopathic Pulmonary Fibrosis: A Degenerative Disease Requiring a Regenerative Approach

Por Glassberg, Marilyn K., Hare, Joshua M., Toonkel, Rebecca L., Matthay, Michael A.
Publicado em 2013

17β-Estradiol Replacement Reverses Age-Related Lung Disease in Estrogen-Deficient C57BL/6J Mice

Por Glassberg, Marilyn K., Choi, Rhea, Manzoli, Vita, Shahzeidi, Shahriar, Rauschkolb, Peter, Voswinckel, Robert, Aliniazee, Muddassir, Xia, Xiaomei, Elliot, Sharon J.
Publicado em 2014

Therapeutic Benefits of Young, But Not Old, Adipose-Derived Mesenchymal Stem Cells in a Chronic Mouse Model of Bleomycin-Induced Pulmonary Fibrosis

Por Tashiro, Jun, Elliot, Sharon J., Gerth, David J., Xia, Xiaomei, Pereira-Simon, Simone, Choi, Rhea, Catanuto, Paola, Shahzeidi, Shahriar, Toonkel, Rebecca L., Shah, Rahil H., El Salem, Fadi, Glassberg, Marilyn K.
Publicado no Transl Res (2015)

A Roadmap to Promote Clinical and Translational Research in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Por Doyle, Tracy J., Lee, Joyce S., Dellaripa, Paul F., Lederer, James A., Matteson, Eric L., Fischer, Aryeh, Ascherman, Dana P., Glassberg, Marilyn K., Ryu, Jay H., Danoff, Sonye K., Brown, Kevin K., Collard, Harold R., Rosas, Ivan O.
Publicado em 2014

Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis

Por Lederer, David J., Bradford, Williamson Z., Fagan, Elizabeth A., Glaspole, Ian, Glassberg, Marilyn K., Glasscock, Kenneth F., Kardatzke, David, King, Talmadge E., Lancaster, Lisa H., Nathan, Steven D., Pereira, Carlos A., Sahn, Steven A., Swigris, Jeffrey J., Noble, Paul W.
Publicado no Chest (2015)

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials

Por Lancaster, Lisa, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, King, Talmadge E, Lederer, David J, Lin, Zhengning, Nathan, Steven D, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, Noble, Paul W
Publicado no BMJ Open Respir Res (2016)

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

Por Noble, Paul W., Albera, Carlo, Bradford, Williamson Z., Costabel, Ulrich, du Bois, Roland M., Fagan, Elizabeth A., Fishman, Robert S., Glaspole, Ian, Glassberg, Marilyn K., Lancaster, Lisa, Lederer, David J., Leff, Jonathan A., Nathan, Steven D., Pereira, Carlos A., Swigris, Jeffrey J., Valeyre, Dominique, King, Talmadge E.
Publicado no Eur Respir J (2016)

The Hedgehog processing pathway is required for NSCLC growth and survival

Por Rodriguez-Blanco, Jezabel, Schilling, Neal S., Tokhunts, Robert, Giambelli, Camilla, Long, Jun, Liang Fei, Dennis, Singh, Samer, Black, Kendall E., Wang, Zhiqiang, Galimberti, Fabrizio, Bejarano, Pablo A., Elliot, Sharon, Glassberg, Marilyn K., Nguyen, Dao M., Lockwood, William W., Lam, Wan L., Dmitrovsky, Ethan, Capobianco, Anthony J., Robbins, David J.
Publicado em 2012

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopa...

Por Nathan, Steven D, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, Glasscock, Kenneth F, King, Talmadge E, Lancaster, Lisa, Lederer, David J, Lin, Zhengning, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, Noble, Paul W, Wells, Athol U
Publicado no Thorax (2016)